The global Immunoassay Market is witnessing strong growth driven by the increasing prevalence of chronic and infectious diseases, rising awareness of early disease detection, and ongoing advancements in diagnostic technologies. According to recent industry analysis, the market size was USD 28.29 billion in 2025 and is projected to grow from USD 29.52 billion in 2026 to USD 42.43 billion by 2034, expanding at a CAGR of 4.64% over the forecast period.

Immunoassays are biochemical tests widely used to detect and quantify specific substances such as proteins, hormones, antibodies, and pathogens in biological samples. These diagnostic solutions have become essential in healthcare systems due to their high sensitivity, accuracy, and rapid testing capabilities.

Growing Burden of Chronic and Infectious Diseases Driving Market Expansion

The rising incidence of chronic illnesses such as cancer, cardiovascular diseases, diabetes, and autoimmune disorders is one of the key factors accelerating the growth of the immunoassay market. At the same time, infectious diseases continue to create a substantial global healthcare burden, increasing the demand for reliable diagnostic tools.

Healthcare providers are increasingly adopting immunoassays because they offer fast and accurate detection, enabling timely treatment decisions and improved patient outcomes. Recent advancements in cardiac biomarker testing, infectious disease screening, and oncology diagnostics are further strengthening the role of immunoassays in modern medicine.

The growing demand for early disease diagnosis has also encouraged the development of highly sensitive assays capable of detecting diseases at early stages. These innovations are improving healthcare efficiency while reducing long-term treatment costs.

Technological Advancements Reshaping the Industry

Rapid technological innovation continues to transform the immunoassay industry. Advanced technologies such as chemiluminescence immunoassays (CLIA), multiplex testing, AI-integrated systems, and automated analyzers are replacing traditional diagnostic methods due to their superior accuracy and faster turnaround times.

Chemiluminescence immunoassays are gaining widespread popularity because they deliver highly sensitive results in a shorter time compared to conventional ELISA methods. Hospitals, diagnostic laboratories, and point-of-care facilities are increasingly adopting these systems to improve testing efficiency and workflow automation.

In addition, the growing adoption of point-of-care immunoassays is expanding access to rapid diagnostics, particularly in emergency care, remote healthcare settings, and infectious disease management. Portable and compact immunoassay analyzers are enabling healthcare professionals to conduct accurate testing closer to patients, reducing dependence on centralized laboratories.

Increasing Investments in Healthcare Infrastructure

Governments and private organizations across the globe are heavily investing in healthcare infrastructure and diagnostic capabilities. Emerging economies in Asia-Pacific, Latin America, and Africa are witnessing rising healthcare expenditure and improved access to diagnostic services, contributing significantly to market growth.

Countries such as India and China are focusing on expanding local manufacturing capabilities for rapid diagnostic kits and immunoassay technologies. Strategic collaborations between diagnostic companies, healthcare institutions, and biotechnology firms are also accelerating innovation and product commercialization.

The increasing focus on personalized medicine and biomarker-based diagnostics is creating new opportunities for immunoassay manufacturers. These technologies are helping clinicians deliver targeted therapies and precision-based treatment approaches for complex diseases.

North America Maintains Market Leadership

North America accounted for the largest share of the global immunoassay market in 2025, supported by advanced healthcare infrastructure, strong research activities, and high adoption of innovative diagnostic technologies. The United States remains a major contributor due to its growing disease burden and increasing investments in biotechnology and life sciences.

Major industry players in the region continue to invest in research and development to strengthen their product portfolios and expand market presence. The integration of artificial intelligence, automation, and multiplex technologies is further enhancing diagnostic accuracy and operational efficiency.

Meanwhile, Asia-Pacific is expected to emerge as the fastest-growing regional market during the forecast period. Rising healthcare awareness, increasing chronic disease prevalence, and supportive government initiatives are driving demand for advanced diagnostic solutions across the region.

Competitive Landscape

The global immunoassay market is moderately fragmented, with several multinational and regional companies competing through technological innovation, product launches, strategic partnerships, and acquisitions. Key players operating in the market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific Inc., bioMérieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., and Labcorp.

Recent industry developments include the launch of next-generation ultrasensitive immunoassay platforms designed for neurological disease diagnostics and advanced biomarker detection technologies aimed at improving precision medicine applications.

Future Outlook

The future of the immunoassay market remains highly promising as healthcare systems increasingly prioritize rapid, accurate, and decentralized diagnostics. The integration of automation, artificial intelligence, and portable testing solutions is expected to revolutionize disease detection and monitoring over the next decade.

Growing applications in oncology, cardiology, infectious disease diagnostics, and veterinary healthcare are likely to create significant opportunities for market players worldwide.

Read Full Immunoassay Market Report -https://straitsresearch.com/report/immunoassay-market

About Straits Research

Straits Research is a leading market research and consulting firm delivering comprehensive industry insights, business intelligence, and customized research solutions to organizations worldwide. The company specializes in providing accurate market forecasts, competitive analysis, and strategic recommendations across multiple industries.